Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer

Cao, X; Li, BL; Chen, J; Dang, J; Chen, SQ; Gunes, EG; Xu, B; Tian, L; Muend, S; Raoof, M; Querfeld, C; Yu, JH; Rosen, ST; Wang, YY; Feng, MY

Feng, MY (corresponding author), City Hope Natl Med Ctr, Dept Immunooncol, Beckman Res Inst, Duarte, CA 91010 USA.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021; 9 (3):

Abstract

Background Limited therapeutic options are available for triple-negative breast cancer (TNBC), emphasizing an urgent need for more effective treatment......

Full Text Link